Canada: Health Minister Backs Free Rx Drug Plan

24 February 1997

Canada's federal Health Minister, David Dingwall, has said he supports acall for prescription drugs to be provided free to consumers through the provincial health plans, saying that this would enable governments to control drug costs, reduce administrative expenses and improve prescribing practices.

The proposal was made in a report on the future of Canada's health care system published this month by the National Forum on Health, a group of 24 academics, doctors and business people appointed by the government in 1994. Mr Dingwall is co-chairman of the Forum, with Prime Minister Jean Chretien.

The report dismisses claims that Medicare is in crisis, saying provincial governments spend sufficiently on health and that there is no need for a private health care system. Forum members attack "fear-mongering and misinformation," which they say has given rise to these fears, and add: "we regret that raising fear among the public is viewed by some as a legitimate way to pursue personal, professional and corporate interests." The report says the system can be improved by reallocating spending, and better management.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight